New Type 2 Diabetes Drug Gets FDA OK

Friday, 01 Aug 2014 04:11 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The U.S. Food and Drug Administration announced on Friday that it approved a new drug, Jardiance, to help fight Type 2 diabetes.

Jardiance (empagliflozin) "can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes," Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research, said in an agency statement.
 
The FDA also recommended that Jardiance be used along with lifestyle changes, such as eating a healthy diet and exercising regularly. The combination of medication and lifestyle modification may improve blood sugar management for people with Type 2 diabetes, they said.

Editor's Note: 3 Signs Your Blood Sugar Is Killing You. Are You At Risk?

More than 26 million Americans are currently affected by Type 2 diabetes, which accounts for about 90 percent of cases of diabetes, according to the agency.

Jardiance, made by Connecticut-based Boehringer Ingelheim Pharmaceuticals, falls into the class of diabetes medicines known as "sodium glucose co-transporter 2 (SGLT2) inhibitors."

These drugs work by stopping blood sugar, or glucose, from getting reabsorbed by the kidneys. That means that more glucose is excreted by the kidneys and blood sugar levels go down, the FDA explained. Other drugs in this class of medications include Invokana (canagliflozin) and Farxiga (dapagliflozin).

The agency said the safety and effectiveness of Jardiance was tested in seven clinical trials involving almost 4,500 people with Type 2 diabetes. The studies showed that Jardiance improved blood sugar levels compared to a "dummy" placebo drug.

The drug has also been studied for use alongside other medications, such as metformin, sulfonylureas, pioglitazone (Actos) and insulin. The FDA stressed that it is ordering post-marketing studies on Jardiance, with a focus on any potential cardiovascular effects, as well as safety and effectiveness in children.

Jardiance can trigger dehydration, which can cause low blood pressure, dizziness and impaired kidney function, the FDA added. This means that elderly people and those with already impaired kidney function may be at heightened risk when taking Jardiance. The drug should not be used by people with type 1 diabetes, according to the FDA.

The most common side effects seen with Jardiance included urinary tract infections and female genital infections, the FDA said.

Editor's Note: 3 Signs Your Blood Sugar Is Killing You. Are You At Risk?

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Surgical Gowns Don't Protect Against Ebola: Lawsuit

Friday, 31 Oct 2014 08:22 AM

A $500 million lawsuit against Kimberly-Clark Corp. alleges the company falsely claimed its surgical gowns protected aga . . .

Medicare Bought Meds for Dead People: Report

Friday, 31 Oct 2014 08:16 AM

Call it drugs for the departed: Medicare's prescription program kept paying for costly medications even after patients w . . .

Leprosy Still Plagues US

Friday, 31 Oct 2014 08:09 AM

Leprosy, although quite rare, continues to appear in the United States, a new U.S. government study reports.
Approx . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved